8 September 2014 Preclinical evaluation of a novel cyanine dye for tumor imaging with in vivo photoacoustic imaging
Author Affiliations +
Abstract
Photoacoustic imaging (PA imaging or PAI) has shown great promise in the detection and monitoring of cancer. Although nanocarrier-based contrast agents have been studied for use in PAI, small molecule contrast agents are required due to their ease of preparation, cost-effectiveness, and low toxicity. Here, we evaluated the usefulness of a novel cyanine dye IC7-1-Bu as a PAI contrast agent without conjugated targeting moieties for
© 2014 Society of Photo-Optical Instrumentation Engineers (SPIE)
Takashi Temma, Takashi Temma, Satoru Onoe, Satoru Onoe, Kengo Kanazaki, Kengo Kanazaki, Masahiro Ono, Masahiro Ono, Hideo Saji, Hideo Saji, } "Preclinical evaluation of a novel cyanine dye for tumor imaging with in vivo photoacoustic imaging," Journal of Biomedical Optics 19(9), 090501 (8 September 2014). https://doi.org/10.1117/1.JBO.19.9.090501 . Submission:
JOURNAL ARTICLE
3 PAGES


SHARE
Back to Top